Zehngebot L M, Alexander M A, Guerry D, Cines D B, Mitchell K, Herlyn M
Cancer Immunol Immunother. 1983;16(1):30-4. doi: 10.1007/BF00199902.
Melanoma cells have been shown to express melanoma-associated antigens and, in many cases, the histocompatibility antigen, HLA-DR. We questioned whether the expression of these antigens was quantitatively altered during the serial passage of melanoma cells in culture. Therefore, we measured the binding of monoclonal antibodies specific for a melanoma-specific antigen and the HLA-DR antigen to melanoma cells from serial passages. Three cell lines were studied. We found that although both the melanoma-associated antigen and the HLA-DR antigen were qualitatively conserved, significant quantitative differences were seen. To study the functional consequences of these differences, we used fluorescence-activated cell sorting to create DR-enriched and DR-depleted populations from a single melanoma cell line heterogeneous for DR expression. We found that the proliferation of allogeneic T cells (measured by the 3H-TdR uptake) cultured with the DR-enriched and -depleted melanoma cell populations was directly related to the amount of the HLA-DR antigen expressed. These results indicate that in performance of experiments using melanoma cell lines quantitative assessment of antigenic expression is important, particularly if the function of a specific antigen is under examination. Further, our data clearly identify the HLA-DR antigen on melanoma cells as a participant in allogeneic lymphocyte stimulation.
黑色素瘤细胞已被证明可表达黑色素瘤相关抗原,并且在许多情况下还可表达组织相容性抗原HLA - DR。我们质疑这些抗原的表达在黑色素瘤细胞培养传代过程中是否会发生定量改变。因此,我们测量了针对黑色素瘤特异性抗原和HLA - DR抗原的单克隆抗体与传代黑色素瘤细胞的结合情况。我们研究了三种细胞系。我们发现,虽然黑色素瘤相关抗原和HLA - DR抗原在性质上是保守的,但在数量上存在显著差异。为了研究这些差异的功能后果,我们使用荧光激活细胞分选技术,从一个DR表达异质性的单一黑色素瘤细胞系中创建了DR富集和DR缺失群体。我们发现,与DR富集和DR缺失的黑色素瘤细胞群体一起培养的同种异体T细胞的增殖(通过3H - TdR摄取来测量)与所表达的HLA - DR抗原的量直接相关。这些结果表明,在使用黑色素瘤细胞系进行实验时,对抗原表达进行定量评估很重要,特别是在检查特定抗原的功能时。此外,我们的数据清楚地表明黑色素瘤细胞上的HLA - DR抗原是同种异体淋巴细胞刺激的参与者。